WO2015024992A3 - Treatment of asthma - Google Patents
Treatment of asthma Download PDFInfo
- Publication number
- WO2015024992A3 WO2015024992A3 PCT/EP2014/067812 EP2014067812W WO2015024992A3 WO 2015024992 A3 WO2015024992 A3 WO 2015024992A3 EP 2014067812 W EP2014067812 W EP 2014067812W WO 2015024992 A3 WO2015024992 A3 WO 2015024992A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- asthma
- treatment
- compositions
- methods
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Abstract
The application is related to compositions and methods for the treatment of asthma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13181411.3 | 2013-08-22 | ||
EP13181411 | 2013-08-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015024992A2 WO2015024992A2 (en) | 2015-02-26 |
WO2015024992A3 true WO2015024992A3 (en) | 2015-04-30 |
Family
ID=49028958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2014/067812 WO2015024992A2 (en) | 2013-08-22 | 2014-08-21 | Treatment of asthma |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015024992A2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024481A2 (en) * | 2001-09-14 | 2003-03-27 | Cytos Biotechnology Ag | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
US20030087848A1 (en) * | 2000-02-03 | 2003-05-08 | Bratzler Robert L. | Immunostimulatory nucleic acids for the treatment of asthma and allergy |
WO2004000351A1 (en) * | 2002-06-20 | 2003-12-31 | Cytos Biotechnology Ag | Packaged virus-like particles for use as adjuvants: method of preparation and use |
WO2005042018A2 (en) * | 2003-10-30 | 2005-05-12 | Coley Pharmaceutical Gmbh | C-class oligonucleotide analogs with enhanced immunostimulatory potency |
WO2007068747A1 (en) * | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
WO2007144150A1 (en) * | 2006-06-12 | 2007-12-21 | Cytos Biotechnology Ag | Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
-
2014
- 2014-08-21 WO PCT/EP2014/067812 patent/WO2015024992A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030087848A1 (en) * | 2000-02-03 | 2003-05-08 | Bratzler Robert L. | Immunostimulatory nucleic acids for the treatment of asthma and allergy |
WO2003024481A2 (en) * | 2001-09-14 | 2003-03-27 | Cytos Biotechnology Ag | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
WO2004000351A1 (en) * | 2002-06-20 | 2003-12-31 | Cytos Biotechnology Ag | Packaged virus-like particles for use as adjuvants: method of preparation and use |
WO2005042018A2 (en) * | 2003-10-30 | 2005-05-12 | Coley Pharmaceutical Gmbh | C-class oligonucleotide analogs with enhanced immunostimulatory potency |
WO2007068747A1 (en) * | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
WO2007144150A1 (en) * | 2006-06-12 | 2007-12-21 | Cytos Biotechnology Ag | Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages |
Non-Patent Citations (5)
Title |
---|
BEEH KAI-MICHAEL ET AL: "The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma.", THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 131, no. 3, March 2013 (2013-03-01), pages 866 - 874, XP002714508, ISSN: 1097-6825 * |
KATO GO ET AL: "Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.", BIOMARKER INSIGHTS, vol. 8, 4 August 2013 (2013-08-04), pages 97 - 105, XP002714510, ISSN: 1177-2719 * |
KNORR B ET AL: "Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.", PEDIATRICS, vol. 108, no. 3, September 2001 (2001-09-01), pages E48, XP002714509, ISSN: 1098-4275 * |
MASSANARI M ET AL: "Effect of omalizumab on peripheral blood eosinophilia in allergic asthma.", RESPIRATORY MEDICINE, vol. 104, no. 2, February 2010 (2010-02-01), pages 188 - 196, XP002714507, ISSN: 1532-3064 * |
PAVORD IAN D ET AL: "Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.", vol. 380, part 9842 18 August 2012, LANCET, ISSN: 1474-547X, pages: 651 - 659, XP002714506 * |
Also Published As
Publication number | Publication date |
---|---|
WO2015024992A2 (en) | 2015-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3030266A4 (en) | Topical compositions and methods of using the same | |
EP2988781A4 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
EP3038610A4 (en) | Compositions and methods for the treatment of presbyopia | |
WO2015085318A3 (en) | Targeted adaptive vaccines | |
EP3060041A4 (en) | Prostacyclin compounds, compositions and methods of use thereof | |
EP3089989A4 (en) | Cas9 crystals and methods of use thereof | |
EP3082819A4 (en) | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | |
EP2961382A4 (en) | Topical compositions and methods of using the same | |
WO2015066452A3 (en) | Methods of treating pediatric cancers | |
HK1214171A1 (en) | Cenicriviroc compositions and methods of making and using the same | |
EP2991946A4 (en) | Pumice-containing remedial compositions and methods of use | |
EP3060611A4 (en) | Aqueous coating composition and process of making the same | |
EP2991658A4 (en) | Antimicrobial compositions and methods of making the same | |
EP2967049A4 (en) | Methods, compounds, and compositions for the treatment of angiotensin-related diseases | |
HK1217896A1 (en) | Compositions and methods for the treatment of pervasive development disorders | |
IL239893A0 (en) | Compositions comprising 15-ohepa and methods of using the same | |
EP3068500A4 (en) | Fertilizer compositions and methods of making and using the same | |
EP3004396A4 (en) | Methods and compositions for the treatment of cancer | |
CA2929436C (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
EP3052078A4 (en) | Methods and compositions for improving the appearance of skin | |
EP3039022A4 (en) | Compositions and methods for the treatment of metabolic and body weight related disorders | |
WO2015092810A3 (en) | Amorphous form of idelalisib | |
HK1220374A1 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
EP3082427A4 (en) | Compositions and methods for treatment of glaucoma | |
EP2958591A4 (en) | Methods and compositions relating to the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14757887 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14757887 Country of ref document: EP Kind code of ref document: A2 |